-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Clostridium difficile infection in obstetrics and gynecology patients
Bogdan I. Stefanescu, Georgiana Bianca Constantin
Mini Review: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Recent trial results in recombinant coagulation factors for the treatment of hemophilia B
Julie Jaffray & Guy Young
Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
Clinical trial success influenced by biomarker- and receptor-targeted therapies
News and Views: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation
-
Update from recent blepharitis clinical trials: interview with James McCulley
James McCulley
Interview: Clinical Investigation